Dr. Reddy's launches novel drug for chronic constipation management
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Prucalopride is prescribed for chronic idiopathic constipation
Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Having a healthy gut is key as it permits the body to build a stronger immune system
Subscribe To Our Newsletter & Stay Updated